tranylcypromine has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Besenbeck, B; Binder, M; Bornhäuser, M; Burhenne, J; Dugas, M; Foerster, KI; Göllner, S; Göthert, JR; Haefeli, WE; Lenz, G; Mikesch, JH; Müller, LP; Müller-Tidow, C; Mundmann, P; Noppeney, R; Pabst, C; Platzbecker, U; Röllig, C; Schlenk, RF; Schliemann, C; Serve, H; Wass, M; Wermke, M | 1 |
| Mielke, D; Ninkovic, M; Rohde, V; Sachkova, A; Schatlo, B; Sperling, S | 1 |
1 trial(s) available for tranylcypromine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy.
Topics: Adult; Aged; Antidepressive Agents; Antineoplastic Agents; Arabidopsis Proteins; DNA-Binding Proteins; Drug Resistance, Neoplasm; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Proof of Concept Study; Prospective Studies; Salvage Therapy; Survival Rate; Transcription Factors; Tranylcypromine; Tretinoin; Young Adult | 2021 |
1 other study(ies) available for tranylcypromine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Combined Applications of Repurposed Drugs and Their Detrimental Effects on Glioblastoma Cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioblastoma; Glycoproteins; Humans; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Riluzole; Temozolomide; Tranylcypromine; Valproic Acid; Xenograft Model Antitumor Assays | 2019 |